DAVID A

“The next day they had lunch, followed by a stroll along the cobblestone streets of old San Juan. When the discussion turned to Cas9, Charpentier became excited. “We have to figure out exactly how it works,” she urged Doudna. “What’s the exact mechanism it uses to cut DNA?”
― Walter Isaacson, The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race

“If we want to define how “open” any industry is, we should start with a number: the cost of entry. By this we simply mean the monetary cost of getting into the business with a reasonable shot at reaching customers. Is it in the neighborhood of $100? $10,000? Or more like $1 billion? Whatever the magnitude, that number, most definitively, is what determines whether an industry is open or closed.”
― Tim Wu, The Master Switch: The Rise and Fall of Information Empires

“Developers and entrepreneurs may someday be able to use CRISPR-based home testing kits as platforms on which to build a variety of biomedical apps: virus detection, disease diagnosis, cancer screening, nutritional analyses, microbiome assessments, and genetic tests. “We can get people in their homes to check if they have the flu or just a cold,” says Zhang.”
― Walter Isaacson, The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race

“The CRISPR-based tests developed by Mammoth and Sherlock are cheaper and faster than conventional PCR tests. They also have an advantage over antigen tests, such as the one developed by Abbott Labs that was approved in August of the plague year. The CRISPR-based tests can detect the presence of the RNA of a virus as soon as a person has been infected. But the antigen tests, which detect the presence of proteins that exist on the surface of the virus, are most accurate only after a patient has become highly infectious to others.”
― Walter Isaacson, The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race